DOCGO INC (DCGO)
US2560861096 - Common Stock
Overall DCGO gets a fundamental rating of 5 out of 10. We evaluated DCGO against 108 industry peers in the Health Care Providers & Services industry. DCGO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DCGO has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year DCGO was profitable.
DCGO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DCGO reported negative net income in multiple years.
In the past 5 years DCGO reported 4 times negative operating cash flow.
1.2 Ratios
DCGO's Return On Assets of 6.24% is amongst the best of the industry. DCGO outperforms 87.85% of its industry peers.
DCGO's Return On Equity of 9.48% is fine compared to the rest of the industry. DCGO outperforms 77.57% of its industry peers.
With an excellent Return On Invested Capital value of 8.61%, DCGO belongs to the best of the industry, outperforming 81.31% of the companies in the same industry.
DCGO had an Average Return On Invested Capital over the past 3 years of 4.74%. This is below the industry average of 8.15%.
The 3 year average ROIC (4.74%) for DCGO is below the current ROIC(8.61%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.24% | ||
| ROE | 9.48% | ||
| ROIC | 8.61% |
ROA(3y)5.95%
ROA(5y)N/A
ROE(3y)8.58%
ROE(5y)N/A
ROIC(3y)4.74%
ROIC(5y)N/A
1.3 Margins
DCGO has a better Profit Margin (4.44%) than 81.31% of its industry peers.
With a decent Operating Margin value of 7.50%, DCGO is doing good in the industry, outperforming 75.70% of the companies in the same industry.
Looking at the Gross Margin, with a value of 34.50%, DCGO is in the better half of the industry, outperforming 61.68% of the companies in the same industry.
In the last couple of years the Gross Margin of DCGO has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.5% | ||
| PM (TTM) | 4.44% | ||
| GM | 34.5% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DCGO is destroying value.
Compared to 1 year ago, DCGO has more shares outstanding
The debt/assets ratio for DCGO is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.83 indicates that DCGO is not in any danger for bankruptcy at the moment.
DCGO has a Altman-Z score of 3.83. This is in the better half of the industry: DCGO outperforms 78.50% of its industry peers.
The Debt to FCF ratio of DCGO is 1.02, which is an excellent value as it means it would take DCGO, only 1.02 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DCGO (1.02) is better than 90.65% of its industry peers.
DCGO has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.12, DCGO is doing good in the industry, outperforming 71.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.02 | ||
| Altman-Z | 3.83 |
ROIC/WACC0.98
WACC8.75%
2.3 Liquidity
DCGO has a Current Ratio of 2.19. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO's Current ratio of 2.19 is fine compared to the rest of the industry. DCGO outperforms 77.57% of its industry peers.
DCGO has a Quick Ratio of 2.19. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO's Quick ratio of 2.19 is fine compared to the rest of the industry. DCGO outperforms 77.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 2.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 262.50% over the past year.
Looking at the last year, DCGO shows a very strong growth in Revenue. The Revenue has grown by 30.17%.
DCGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 87.90% yearly.
EPS 1Y (TTM)262.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)30.17%
Revenue growth 3Y87.9%
Revenue growth 5YN/A
Sales Q2Q%-25.66%
3.2 Future
Based on estimates for the next years, DCGO will show a very strong growth in Earnings Per Share. The EPS will grow by 36.36% on average per year.
DCGO is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.76% yearly.
EPS Next Y324.66%
EPS Next 2Y24.95%
EPS Next 3Y36.36%
EPS Next 5YN/A
Revenue Next Year0.95%
Revenue Next 2Y-17.78%
Revenue Next 3Y-9.76%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.10, which indicates a correct valuation of DCGO.
Compared to the rest of the industry, the Price/Earnings ratio of DCGO indicates a somewhat cheap valuation: DCGO is cheaper than 78.50% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. DCGO is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 40.08, the valuation of DCGO can be described as expensive.
DCGO's Price/Forward Earnings is on the same level as the industry average.
DCGO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.73.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.1 | ||
| Fwd PE | 40.08 |
4.2 Price Multiples
93.46% of the companies in the same industry are more expensive than DCGO, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 86.92% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.38 | ||
| EV/EBITDA | 5.55 |
4.3 Compensation for Growth
DCGO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DCGO's earnings are expected to grow with 36.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y24.95%
EPS Next 3Y36.36%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DOCGO INC
NASDAQ:DCGO (12/23/2024, 11:55:57 AM)
4.38
-0.13 (-2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners54%
Inst Owner Change1.05%
Ins Owners9.82%
Ins Owner Change7.35%
Market Cap446.98M
Analysts84.62
Price Target6.34 (44.75%)
Short Float %6.82%
Short Ratio11.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.79%
Min EPS beat(2)-8.5%
Max EPS beat(2)0.93%
EPS beat(4)2
Avg EPS beat(4)-4.64%
Min EPS beat(4)-31.37%
Max EPS beat(4)20.4%
EPS beat(8)3
Avg EPS beat(8)-47.91%
EPS beat(12)6
Avg EPS beat(12)72.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.39%
Max Revenue beat(2)-0.57%
Revenue beat(4)2
Avg Revenue beat(4)-0.29%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)0.58%
Revenue beat(8)5
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)21.88%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)6.26%
EPS NQ rev (3m)-14.29%
EPS NY rev (1m)11.48%
EPS NY rev (3m)11.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.22%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)0.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.1 | ||
| Fwd PE | 40.08 | ||
| P/S | 0.64 | ||
| P/FCF | 10.38 | ||
| P/OCF | 8.67 | ||
| P/B | 1.37 | ||
| P/tB | 1.84 | ||
| EV/EBITDA | 5.55 |
EPS(TTM)0.29
EY6.62%
EPS(NY)0.11
Fwd EY2.5%
FCF(TTM)0.42
FCFY9.64%
OCF(TTM)0.5
OCFY11.53%
SpS6.81
BVpS3.19
TBVpS2.37
PEG (NY)0.05
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.24% | ||
| ROE | 9.48% | ||
| ROCE | 15.18% | ||
| ROIC | 8.61% | ||
| ROICexc | 11.32% | ||
| ROICexgc | 15.97% | ||
| OM | 7.5% | ||
| PM (TTM) | 4.44% | ||
| GM | 34.5% | ||
| FCFM | 6.2% |
ROA(3y)5.95%
ROA(5y)N/A
ROE(3y)8.58%
ROE(5y)N/A
ROIC(3y)4.74%
ROIC(5y)N/A
ROICexc(3y)11.17%
ROICexc(5y)N/A
ROICexgc(3y)17.48%
ROICexgc(5y)N/A
ROCE(3y)7.8%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5YN/A
F-Score7
Asset Turnover1.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.02 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 49.23% | ||
| Cap/Sales | 1.22% | ||
| Interest Coverage | 33.07 | ||
| Cash Conversion | 74.33% | ||
| Profit Quality | 139.73% | ||
| Current Ratio | 2.19 | ||
| Quick Ratio | 2.19 | ||
| Altman-Z | 3.83 |
F-Score7
WACC8.75%
ROIC/WACC0.98
Cap/Depr(3y)69.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)262.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y324.66%
EPS Next 2Y24.95%
EPS Next 3Y36.36%
EPS Next 5YN/A
Revenue 1Y (TTM)30.17%
Revenue growth 3Y87.9%
Revenue growth 5YN/A
Sales Q2Q%-25.66%
Revenue Next Year0.95%
Revenue Next 2Y-17.78%
Revenue Next 3Y-9.76%
Revenue Next 5YN/A
EBIT growth 1Y243.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year289.16%
EBIT Next 3Y35.39%
EBIT Next 5YN/A
FCF growth 1Y66.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.1%
OCF growth 3YN/A
OCF growth 5YN/A